https://www.reuters.com/article/us-vaccitech-ipo/vaccitech-prices-shares-at-17-for-u-s-ipo-idUSKBN2CH012 >Vaccitech Plc, the biotech startup that owns the technology behind the COVID-19 vaccine developed by Oxford University and AstraZeneca Plc, priced its ordinary shares at $17 each on Thursday ahead of its U.S. initial public offering.